JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Thermo Fisher Scientific Inc

Cerrado

SectorSanidad

573.3 0.2

Resumen

Variación precio

24h

Actual

Mínimo

572.08

Máximo

575.73

Métricas clave

By Trading Economics

Ingresos

100M

1.6B

Ventas

491M

11B

P/B

Media del Sector

31.148

37.461

Rentabilidad por dividendo

0.3

Margen de beneficios

14.878

Empleados

125,000

EBITDA

1.1B

2.8B

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+6.88% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

0.30%

2.33%

Próxima Fecha de Ex Dividendo

12 dic 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

52B

205B

Apertura anterior

573.1

Cierre anterior

573.3

Noticias sobre sentimiento de mercado

By Acuity

32%

68%

76 / 371 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Thermo Fisher Scientific Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

23 oct 2025, 20:49 UTC

Ganancias

Correction to Thermo Fisher Article on Oct. 22

22 oct 2025, 10:28 UTC

Ganancias

Thermo Fisher 3Q Revenue Rises, Boosted by Life Sciences Business

23 jul 2025, 10:33 UTC

Ganancias

Thermo Fisher Scientific 2Q Profit, Revenue Rise

25 jun 2025, 21:19 UTC

Adquisiciones, fusiones, absorciones

Solventum Removes Drinking-Water Unit From Thermo Fisher's Planned Filtration Buy

28 may 2025, 14:02 UTC

Adquisiciones, fusiones, absorciones

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34 Billion

23 abr 2025, 10:33 UTC

Ganancias

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

22 oct 2025, 10:01 UTC

Ganancias

Thermo Fisher 3Q Organic Revenue Rose 3% >TMO

22 oct 2025, 10:00 UTC

Ganancias

Thermo Fisher: In Great Position to Deliver on 2025 Objectives >TMO

22 oct 2025, 10:00 UTC

Ganancias

Thermo Fisher 3Q Adj EPS $5.79 >TMO

22 oct 2025, 10:00 UTC

Ganancias

Thermo Fisher 3Q Rev $11.12B >TMO

22 oct 2025, 10:00 UTC

Ganancias

Thermo Fisher 3Q Net $1.62B >TMO

22 oct 2025, 10:00 UTC

Ganancias

Thermo Fisher 3Q EPS $4.27 >TMO

2 sept 2025, 12:15 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Scientific Completes Acquisition Of Sanofi's Ridgefield, New Jersey Site >TMO

2 sept 2025, 12:08 UTC

Adquisiciones, fusiones, absorciones

Solventum Had Seen 2025 Adjusted EPS $5.80-$5.95 >SOLV

2 sept 2025, 12:08 UTC

Adquisiciones, fusiones, absorciones

Solventum Raises 2025 View To Adj EPS $5.88-Adj EPS $6.03 >SOLV

2 sept 2025, 12:04 UTC

Adquisiciones, fusiones, absorciones

Solventum to Use Net Proceeds Primarily to Pay Down Debt >SOLV

2 sept 2025, 12:03 UTC

Adquisiciones, fusiones, absorciones

Solventum Closes Sale of Unit to Thermo Fisher for $4 Billion in Cash >SOLV

2 sept 2025, 12:03 UTC

Adquisiciones, fusiones, absorciones

Thermo Fisher Completes Acquisition of Purification & Filtration Business of Solventum for About $4B in Cash >TMO

2 sept 2025, 12:00 UTC

Adquisiciones, fusiones, absorciones

Solventum Completes Sale of Purification & Filtration Business to Thermo Fisher Scientific >SOLV TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Organic Revenue Rose 2% >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Adj EPS $5.36 >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Net $1.62B >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q EPS $4.28 >TMO

23 jul 2025, 10:00 UTC

Ganancias

Thermo Fisher 2Q Rev $10.85B >TMO

14 jul 2025, 16:12 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 jul 2025, 15:06 UTC

Adquisiciones, fusiones, absorciones

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

28 may 2025, 13:47 UTC

Adquisiciones, fusiones, absorciones

Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

23 abr 2025, 10:01 UTC

Ganancias

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 abr 2025, 10:00 UTC

Ganancias

Thermo Fisher 1Q EPS $3.98 >TMO

Comparación entre iguales

Cambio de precio

Thermo Fisher Scientific Inc previsión

Precio Objetivo

By TipRanks

6.88% repunte

Estimación a 12 Meses

Media 611.88 USD  6.88%

Máximo 675 USD

Mínimo 561 USD

De acuerdo con 19 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Thermo Fisher Scientific Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

19 ratings

16

Comprar

3

Mantener

0

Vender

Puntuación técnica

By Trading Central

406.5 / 417.79Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Strong Bearish Evidence

Sentimiento

By Acuity

76 / 371 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
help-icon Live chat